Incidence and prognostic value of HER2-low expression metastatic breast cancer in Asian population: A 10-year retrospective study

被引：0
|
作者：
Dajsakdipon, T. [1 ]
Pipatsakulroj, W. [2 ]
Dejthevaporn, T. [3 ]
机构：
[1] Ramathibodi Hosp, Dept Med, Bangkok, Thailand
[2] Mahidol Univ, Fac Med, Ramathibodi Hosp, Dept Pathol, Bangkok, Thailand
[3] Mahidol Univ, Fac Med, Ramathibodi Hosp, Internal Med Dept, Bangkok, Thailand
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.610
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
434P
引用
收藏
页码：S364 / S364
页数：1
相关论文
共 50 条
  • [31] HER2-low metastatic breast cancer: molecular insights and therapeutic strategies
    Esteva, Francisco J.
    Jaffer, Shabnam
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2023, 9
  • [32] Targeting HER2-low in metastatic breast cancer: an evolving treatment paradigm
    Yang, Charlie
    Brezden-Masley, Christine
    Joy, Anil Abraham
    Sehdev, Sandeep
    Modi, Shanu
    Simmons, Christine
    Henning, Jan-Willem
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [33] The Dynamic of HER2-low Expression during Breast Cancer Progression
    Anderson, Sarah
    Bartow, Brooke
    Huang, Xiao
    Wei, Shi
    LABORATORY INVESTIGATION, 2023, 103 (03) : S89 - S89
  • [34] HER2-low breast cancer brain metastases: Incidence and treatment implications
    Chehade, Rania
    Nofech-Mozes, Sharon
    Plotkin, Anna
    Moravan, Veronika
    Jerzak, Katarzyna Joanna
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [35] Retrospective analysis of HER2-low in young breast cancer patients.
    Omar, Abeid Mohamed Athman
    Darwish, Azza Mohamad Amin
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [36] The dynamics of HER2-low expression during breast cancer progression
    Anderson, Sarah
    Bartow, Brooke Baxter
    Siegal, Gene P.
    Huang, Xiao
    Wei, Shi
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 201 (03) : 437 - 446
  • [37] The dynamics of HER2-low expression during breast cancer progression
    Sarah Anderson
    Brooke Baxter Bartow
    Gene P. Siegal
    Xiao Huang
    Shi Wei
    Breast Cancer Research and Treatment, 2023, 201 : 437 - 446
  • [38] HER2-low inflammatory breast cancer: Clinicopathologic features and prognostic implications
    Tarantino, Paolo
    Niman, Samuel M.
    Erick, Timothy K.
    Priedigkeit, Nolan
    Harrison, Beth T.
    Giordano, Antonio
    Nakhlis, Faina
    Bellon, Jennifer R.
    Parker, Tonia
    Strauss, Sarah
    Jin, Qingchun
    King, Tari A.
    Overmoyer, Beth A.
    Curigliano, Giuseppe
    Regan, Meredith M.
    Tolaney, Sara M.
    Lynce, Filipa
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : 277 - 286
  • [39] Incidence and outcome of brain and/or leptomeningeal metastases in HER2-low metastatic breast cancer in the French ESME cohort
    Epaillard, N.
    Lusque, A.
    Jacot, W.
    Mailliez, A.
    Bachelot, T.
    Arnedos, M.
    Le Du, F.
    Brain, E.
    Ferrero, J. M.
    Massard, V.
    Desmoulins, I.
    Mouret-Reynier, M. A.
    Levy, C.
    Goncalves, A.
    Leheurteur, M.
    Petit, T.
    Filleron, T.
    Bosquet, L.
    Pistilli, B.
    Frenel, J. S.
    ESMO OPEN, 2024, 9 (05)
  • [40] Clinical characteristics and prognostic implications in patients with HER2-low breast cancer undergoing neoadjuvant chemotherapy: a retrospective cohort study
    Zheng, Ang
    He, Junlin
    Li, Muyao
    Yao, Fan
    Jin, Feng
    Chen, Bo
    Wang, Xin
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2025, 55
12345